Incorporation of PBRM1, BAP1, TP53 mutation status into the Memorial Sloan Kettering Cancer Center (MSKCC) risk model: A genomically annotated tool to improve stratification of patients (pts) with advanced renal cell carcinoma (RCC) Meeting Abstract
| Authors: | Voss, M. H.; Cheng, Y.; Marker, M.; Kuo, F.; Choueiri, T. K.; Hsieh, J. J.; Reising, A.; Motzer, R. J.; Hakimi, A. A. |
| Abstract Title: | Incorporation of PBRM1, BAP1, TP53 mutation status into the Memorial Sloan Kettering Cancer Center (MSKCC) risk model: A genomically annotated tool to improve stratification of patients (pts) with advanced renal cell carcinoma (RCC) |
| Meeting Title: | 2018 Genitourinary Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 36 |
| Issue: | 6 Suppl. |
| Meeting Dates: | 2018 Feb 8-10 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2018-02-20 |
| Language: | English |
| ACCESSION: | WOS:000436179500633 |
| DOI: | 10.1200/JCO.2018.36.6_suppl.639 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 639 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work